Home
Search results “Takeda medical blood pressure”
UA 767
 
01:08
A&D Blood pressure monitor Model UA-767. A quick overview as to its use and function, By www.idass.com
Views: 17316 IDASS
果てしなき欲望 - Hateshinaki yokubô - Endless Desire (1958)  Shôhei Imamura
 
01:40:30
A real gem from Imamura. A very dark crime comedy. plot: On August 15, ten years after the Pacific War, five people meet at a station. Their purpose is to dig out a cache of morphine -- now worth sixty million yen -- that HASHIMOTO, an army medical officer, buried in an air-raid shelter in this city on the day the war ended. The five are: SHIMA, a beautiful woman who claims that she is HASHIMOTO's younger sister and that her brother is dead; NAKADA, a pharmacist; ONUMA, who owns a Chinese restaurant; YAMAMOTO, a thug; and SAWAI, who says he is a junior high school teacher. But HASHIMOTO originally had only three accomplices -- and hid the morphine late at night, so they did not know each other's identities. There is one person too many in the group, but they do not know whom. A butcher shop now stands over the old air-raid shelter Director: Shôhei Imamura Writers: Shinji Fujiwara (based on the novel by), Shôhei Imamura (screenplay) Stars: Hiroyuki Nagato, Misako Watanabe, Kô Nishimura Storyline
Views: 80748 DropOut 2018
Сложные вопросы диагностики и лечения артериальной гипертензии и ИБС . Арутюнов Г.П.2015
 
56:47
Лекция на тему "Сложные вопросы диагностики и лечения АГ и ИБС в практике терапевта ". Лектор :Арутюнов Григорий Павлович - президент Евразийской ассоциации терапевтов, заведующий кафедрой внутренних болезней и общей физиотерапии Российского национального исследовательского медицинского университета имени Н.И. Пирогова, Заслуженный врач России, доктор медицинских наук, профессор.
Views: 20317 5hostelify
The vision of Servier in Oncology
 
01:37
Marion Schrenk, Head of Global Medical Affairs and Product Strategy Oncology, outlines the vision of Servier in oncology and its commitment to translate cutting-edge science into therapies for patients through innovation and excellence. http://servier-oncology.com/
Views: 1947 Servier
Rozerem - Your Dreams Miss You
 
01:02
New Rozerem Ad Campaign. Possibly the best prescription drug ad since the FDA relaxed the rules on drug advertising.
Views: 76559 Mark Lewis
Lunesta a Prescription Medication Used to Treat Insomnia - Information
 
00:29
http://www.rxwiki.com/lunesta https://www.youtube.com/watch?v=6ynJLZbqrBk&list=PLXxn_pCvHVm76zGRgKB9Rf95aqo1nSN02 Lunesta is a prescription medication used to treat insomnia (difficulty falling or staying asleep). Lunesta belongs to a group of drugs called hypnotics. It works by slowing brain activity to allow you to sleep.This medication comes in tablet form and is taken once daily, immediately before bedtime.Common side effects of this medication may include unpleasant taste, dry mouth, and dizziness.
Views: 339 RxWikiTV
A Miracle "Cure" for Nicole
 
04:06
Dr. David Teachey, with support from Cures Within Reach, creates a "new" treatment for Nicole from an old drug, Rapamycin. Hear from Nicole and her parents about how Nicole went from death's doorstep to an almost normal life because of the two pills she takes every day. The best kept secret in medicine is that everything we use to treat diseases can be repurposed to treat other diseases-like aspirin for headaches AND heart attacks, Benadryl for allergies AND insomnia, Viagra for erectile dysfunction AND pulmonary hypertension. There are 1000s of drugs and nutriceuticals just waiting to be tested for repurposing, especially for rare diseases. Learn about how you can help turn this best kept secret into the best used solution to help someone you know with a catastrophic disease.
Views: 439 CuresWithinReach
Collecting and Connecting the Pharma Informatics Dots with Digital Health Technology
 
20:31
This talk was given at DHS Turkey, to a room full of Pharmaceutical Industry and Digital Health (Healthcare IT) professionals in September 2014. The focus was on digital health opportunities and where innovators, healthcare providers, pharmaceutical manufacturers, and related technologists should focus their attention.
Views: 177 Shahid Shah
insomnia depression and blood pressure By PROF. DR. ABDUL SAMAD (Part-1)
 
15:18
HEALTH WEALTH & HAPPINESS Program By: Prof. Dr. Abdul Samad, the Founder & Chief Trainer World Zheel Sciences Web: www.zheelsciences.com
Views: 286 DrAbdulsamadm
News Update: Orexigen Soars on High Hopes for Obesity Treatment
 
00:53
Jun 28, 2010 -- Orexigen Therapeutics Inc (OREX) is surging ahead in morning trade after the drug maker presented positive data for its obesity treatment before the American Diabetes Association. The drug Contrave is expected to be reviewed by the FDA Dec. 7. Shares in the San Diego-based company opened at $4.41, and have traded between $4.00 and $10.83 over the past 12 months. Companies: Orexigen Therapeutics Inc Price: 4.79 Price Change: +0.64 Percent Change: +15.42
Views: 131 TradeTheTrend
Curing Diabetes: Ending an Epidemic in the Latino/Hispanic Community
 
27:22
By http://MetabolicCoaching.NET. A great description of how INSULIN RESISTANCE leads to DIABETES. Recommended for every type 2 diabetic. It also explains how a low carb diet REVERSES insulin resistance and CURES diabetes. Schedule at http://MetabolicCoaching.NET. Local & Online Distance Metabolic Coaching Available. Join us for our monthly webinar or weekly local courses! “Curing Diabetes: Ending an Epidemic in the Latino/Hispanic Community” was presented at the Texas Tech International Cultural Center April 22, 2016 at the annual LHFSA Cultural Awareness Seminar. Type 2 Diabetes On the American Diabetes Association (ADA) website it states, “Type 2 diabetes is a progressive and chronic condition…” See http://www.diabetes.org/newsroom/press-releases/2014/american-diabetes-association-takeda-launch-connect2day.html#sthash.aN6HexQn.dpuf. “Progressive” means it gets worse with time. “Chronic” means you have the disease long term… But this doesn’t have to be the case. Learn how type 2 diabetes is actually REVERSIBLE with the right diet. Diabetes in the Latino/Hispanic Community in Texas - 11% of the Hispanic community has type 2 diabetes (vs. 8.2% white) - The mortality rate for the Hispanic community from diabetes is TWICE that of the white population - 4.3% of the Hispanic community is pre-diabetic - Over 1.4 million in the Hispanic community are diabetic or pre-diabetic What is type 2 diabetes? It is INSULIN RESISTANCE. Here’s how… Normal Metabolism of Carbohydrates When someone eats carbohydrates (carbs), they are metabolized into blood sugar. The blood sugar goes up. This causes the pancreas to secrete insulin. The cells respond to the insulin by storing away the sugar (most of it as fat). This makes the blood sugar go down. The person feels hungry when the blood sugar is down. So they eat more carbs. That is normal carb metabolism (i.e. normal glucose metabolism). Insulin Resistance - The Development of Diabetes When someone eats too many carbs (meaning more than their individual body/metabolism can handle) their sugar goes TOO HIGH TOO OFTEN. This causes the pancreas to make TOO MUCH INSULIN. Then the cells, because they are bombarded by too much insulin too often, begin to resist the effects of insulin. This is called INSULIN RESISTANCE. Since the cells are insulin resistant, they are not storing away the sugar (the cells do not clear the sugar from the blood stream), and the sugar STAYS HIGH. This causes the pancreas to make EVEN MORE insulin. Which makes the insulin resistance EVEN WORSE. As long as the person keeps feeding TOO MANY CARBS into the system, the vicious cycle of insulin resistance with continue. In genetically susceptible people, they can develop TYPE 2 DIABETES. Summary of Type 2 Diabetes The CAUSE = HIGH CARB DIET + genetics. You don’t control your genetics. The only thing you do control is the amount of carbs in the diet. The DISEASE = INSULIN RESISTANCE. That means we call the disease “Type 2 Diabetes.” However that is just a name. The real disease process is actually insulin resistance. The SYMPTOM = HIGH BLOOD SUGAR. High blood sugar is just a symptom of the disease (insulin resistance). So just treating your blood sugar does not address either the CAUSE or the actual DISEASE. Type 2 Diabetics actually make TOO MUCH insulin. And the more they make, the worse their disease gets, meaning the worse their insulin resistance gets, meaning the worse their diabetes gets! DESCRIPTION CONTINUED IN THE COMMENTS………………. Live in Lubbock? Then schedule online for your Live Metabolic Coaching session in Lubbock at http://MetabolicCoaching.NET today! Don’t live in Lubbock? You can learn the Metabolic Coaching diet these clients followed to improve their health by watching the videos 1-7 at: http://metaboliccoaching.net/free-content. Written instructions, the audio version, and low-carb meditations can be found at: http://metaboliccoaching.net/free-content This communication is for informational purposes only and does not constitute medical advice. Any health and/or lifestyle modification program should be undertaken only under the direct supervision of your doctor. Individual results may vary. DESCRIPTION CONTINUED IN THE COMMENTS……………….
Bladder Cancer and Actos Side Effects
 
02:46
This video brought to you by http://www.duejustice.com. Actos, an oral Type II diabetes drug, was given FDA approval in 1999 and was supposedly safe. Research has shown, however, that using Actos may cause, among other side effects like liver failure and heart disease, an increased risk of bladder cancer -- and the risk grows the longer Actos is taken. Our product liability attorneys strongly believe that Takeda Pharmaceuticals, the manufacturer of Actos, must be held accountable for the damages caused by this dangerous drug. Actos is still being prescribed under a "black box warning" but studies continue to show a strong link between the drug and bladder cancer. If you or a loved one has been diagnosed with bladder cancer after taking Actos, our product liability lawyers can help. There are never any upfront costs or fees and we help people across the United States. Summary: http://www.duejustice.com/defective-product-liability/actos-side-effect-lawsuit/ "Do Not Use" List - Actos: http://www.duejustice.com/legal-news/articles/do-not-use-actos/ Actos Bladder Cancer Lawsuits Mount: http://www.duejustice.com/legal-news/articles/actos-lawsuits/ Kelley Law Group, P.C. 4 Court Street Plymouth, Massachusetts 02360 Tel: (888) KLG-ATTY Fax: (888) 554-2889 http://www.duejustice.com
Views: 788 kelleylawgroup
Hair Transplant Miami: Post-Op Beard Hair Transplant
 
04:37
Miami Hair Transplant Surgeon, Dr. Anthony Bared presents a patients 1 day post-operative results from a FUE beard hair transplant procedure. Phone: 800-943-7295 Learn More: http://facialplasticsurgerymiami.com/har-transplants/facial-hair-transplantation/ Book a Consultation: http://facialplasticsurgerymiami.com/consultations/
FDA Approves Contrave, Third Weight-Loss Drug In 2 Years
 
02:03
The FDA has approved yet another weight-loss drug. This one combines an anti-depressant with a drug used to combat addiction. Is it worth the risk? Follow Sebastian Martinez: http://www.twitter.com/sebastiansings See more at http://www.newsy.com Sources: ABC http://abcnews.go.com/topics/lifestyle/health/contrave.htm NBC http://www.nbcphiladelphia.com/news/health/FDA-Approves-Weight-Loss-Drug-Contrave-274732541.html Food and Drug Administration http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm CNET https://www.youtube.com/watch?v=uWnaqsLSl8c NPR http://www.npr.org/blogs/health/2011/02/02/133398572/fda-rejects-diet-pill-casting-pall-over-future-of-weight-loss-medicines The New York Times http://www.nytimes.com/2014/09/11/business/new-drug-to-treat-obesity-gains-approval-by-fda.html Image via: Euroclinix.net http://www.euroclinix.net/contrave.html
Views: 1069 Newsy Science
Deshaies (Amgen) 3: Targeting the ubiquitin-proteasome system in cancer
 
41:45
https://www.ibiology.org/cell-biology/primer-ubiquitin-proteasome-system/#part-3 Part 1: A primer on the ubiquitin-proteasome system: The ubiquitin-proteasome system is one of the principal means of degrading misfolded, mutated, or unwanted proteins in the cell. Part 2: Cullin-RING ubiquitin ligases: Over 200 types of cullin-RING ubiquitin ligases are formed by interchanging subunits. This carefully regulated system allows for great substrate specificity. Part 3: Targeting the ubiquitin-proteasome system in cancer: The ubiquitin-proteasome system is overworked in mutation-ridden cancer cells making it a potential target for anti-cancer drugs. Talk Overview: Neurons, blood cells and muscle cells have distinct morphologies and functions because they have different proteomes or collections of proteins. The proteome is maintained through the synthesis and degradation of different proteins.  In his first talk, Dr. Deshaies explains that the ubiquitin-proteasome system (UPS) is the principal means of degrading proteins in the cytosol and therefore is key to maintaining the proteome.  Ubiquitin is a small protein that can be added to, or removed from, other proteins altering their function or targeting them for degradation. Deshaies describes the multiple mechanisms for regulating ubiquitin ligase activity and the importance of protein degradation in many cell signaling pathways and in the removal of defective proteins.   In Part 2, Deshaies delves more deeply into a specific group of ubiquitin ligases, the cullin-RING ligases (CRLs). By rearranging the subunits of CRLs in a combinatorial process, it is possible to generate more than 200 of these enzymes each with a specific substrate.  The formation and activity of CRL complexes in the cell is regulated by the conjugation/deconjugation (Nedd8) or binding/dissociation (Cand1) of other proteins to the CRL complex, and this, in turn, is influenced by the binding of substrate to CRL. This carefully regulated mechanism allows cells to match the level and specificity of ubiquitin ligation to the level of particular substrates in the cell. In many types of cancer, cells have a very high rate of mutation.  These mutated proteins are frequently less stable than normal proteins and need to be degraded by the UPS. In addition, cancer cells are often aneuploid leading to the overexpression of certain proteins. These extra proteins also need to be degraded by the UPS. In both cases, the UPS in cancer cells is overworked.  This suggests that cancer cells should be less able to tolerate inhibition of the UPS than normal cells.  In his last talk, Deshaies describes strategies to develop cancer drugs based on inhibition of the UPS. Speaker Biography: At the time that this video was recorded, Dr. Raymond Deshaies was a Professor of Biology at the California Institute of Technology and an Investigator of the Howard Hughes Medical Institute. Deshaies will be transitioning to a new position as Senior Vice President for Discovery Research at Amgen, in 2017. Deshaies received his BS in biochemistry from Cornell University and his PhD, also in biochemistry, from the University of California, Berkeley.  It was as a post-doctoral fellow at the University of California, San Francisco, that Deshaies found that a cell cycle protein he was investigating was modified by the addition of ubiquitin.  This began a career-long interest in the role of the ubiquitin-proteasome system in regulating protein homeostasis, both in normal cell function and in diseases such as cancer. Deshaies has received numerous awards for his outstanding research.  He has been elected as a Fellow of the American Association for the Advancement of Science (2007), as a Member of the American Academy of Arts and Sciences (2011) and as a Member of the US National Academy of Sciences (2016). Learn more about Deshaies’ research here: http://www.deshaieslab.com/ray-deshaies.html
Views: 2047 iBiology
Biological Clock- Conceptual Art
 
01:02
Changing the perception of 1 minute. I became intrigued by the essence of the relationship between life and time.
Views: 335 sperre6231
ERS Inteview: Dr Alan Kaplan on reducing risk as part of COPD treatment
 
11:53
http://bit.ly/N87OLK PMLiVE interview with Dr Alan Kaplan, chair of the Respiratory Medicine Special Interest Focus Group of the College of Family Physicians of Canada, about his role in the The Shifting Paradigm in COPD Management Report. Dr Kaplan explains the increasing importance in reducing risk as part of COPD treatment, as well as what the COPD healthcare community can learn from progress in heart disease. The interview took place at the European Respiratory Society Annual Congress in Vienna, Austria, during September 2012. Read the PMLiVE article at: http://bit.ly/N87OLK
Views: 753 Web Editor
John Nosta: Saving lives daily with effortless medical monitoring
 
06:33
Sensors that measure whether your heart rate is up, if you're eating too much, or if your sugar levels are okay are just a few ways technology can improve our health. The key, according to John Nosta, is developing and using devices that can build a patient dashboard allowing people to ultimately collaborate with their doctors. An executive vice president at the communications company Ogilvy CommonHealth Worldwide, Nosta believes technology can improve health outcomes by giving patients the tools to work better with their health care providers, by taking charge or their health data and better interpreting what it means. A long-time expert in health and wellness issues, Nosta was a research associate at Harvard Medical School and is currently a contributing editor at Forbes Magazine.
Drama CD 06 -  This Time it's the Ultimate Ma!Weapon!‏‏ (Subtitled)
 
01:08:32
Drama CD 06 - This Time it's the Ultimate Ma!Weapon!‏‏ Note: This is the Honke version, which has an extra track: 'The pains of His Excellency Gwendal' . The last track "Cast talk" is not subtitled, it's a section with comments of the seiyuus, a random chat. Download audios ➜ https://goo.gl/RkB557 All drama CDs translated ➜ https://goo.gl/CqLxQS All novel translations ➜ https://goo.gl/1UA7fh TRACK LIST 0:03 Track 1: Prologue 03:20 Track 2: A Luxury Liner full of dangers 14:40 Track 3: At that time in Shin Makoku 21:02 Track 4: It's been one disaster after another 31:29 Track 5: Demon Sword Morgif ・A casual trip to the steamy hot springs 36:58 Track 6: Their respective paths 43:35 Track 7: Going back home going back home 49:23 Track 8: Epilogue (Murakenzu) 52:18 Track 9: The pains of His Excellency Gwendal 1:00:29 Track 10: Cast Talk INFORMATION Original Title: 裏マ 今度はマのつく最終兵器! Release date: June 24, 2005 Two versions: Honke Special (本家すぺしゃるVer.) with extra track and Ganzo Gorgeous (元祖ごーじゃすVer.). Cast:(Yuuri) Sakurai Takahiro; (Conrad) Morikawa Toshiyuki; (Wolfram) Saiga Mitsuki; (Gunter) Inoue Kazuhiko; (Gwendal) Ootsuka Akio; (Cherie) Katsuki Masako ; (Josak) Takeda Masanori ; (Murata) Miyata Kouki ; (Shouri) Konishi Katsuyuki. Original work: Takabayashi Tomo (喬林知) Screenplay: Takahashi Makio(高橋槇生)
Views: 13106 RedGlassesGirl MAruma
How to Talk with your Healthcare Team about What’s Best for You
 
01:00:44
Join the IMF’s Nurse Leadership Board members, Beth Faiman and Charise Gleason, for a Living Well with Myeloma webinar on Shared Decision Making – How to talk with your healthcare team about what’s best for you. Patients face many challenges as they move through their journey with myeloma including how to effectively communicate with their healthcare team on their personal goals for treatment and relate what is most important about their care to them. This webinar will introduce patients to shared decision making and provide case studies illustrating successful communication between patients and healthcare providers that illustrate how to have more productive conversations with their healthcare team. Please subscribe to our channel! Subscribe to International Myeloma Foundation: http://bit.ly/XlUtPE Visit our website at: https://www.myeloma.org Find us online: Facebook: http://facebook.com/myeloma Google+: http://gplus.to/imfmyeloma IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma) Dr. Durie on twitter: @BrianDurieMD (http://twitter.com/brianduriemd) Support the IMF! http://bit.ly/WskQHC Category Nonprofits & Activism License Standard YouTube License
Company Profile: Daiichi Sankyo, Inc.
 
02:13
Glenn Gormley, Chief Science Officer and President of Daiichi Sankyo Pharma Development, emphasizes the importance of innovation and collaboration in finding new cures for cancer.
Views: 4968 PhRMAPress
Insomnia on Doc Talk with Dr. Tyler
 
11:07
www.osfstjoseph.org - OSF St. Joseph Medical Center and Cities 92.9 provides comprehensive medical information you can use!
Views: 98 OSFSJMC
tensiometro digital analogo #76
 
00:53
¿Te gustó? Cómpralo en MercadoLibre. http://www.mercadolibre.com/jms/mco/ml.youtube.dispatcher.YouTubeDispatcher?title=tensiometro+digital+analogo+semiatomatico%2C+lcd+memoria+salud&categ_id=44504&item_site_id=MCO&auction_stop=05-01-2010&item_id=10579089
Views: 19607 mlvideos0083
CSL Video
 
04:45
In this fast moving world, it seems as so many take the pharmaceutical industry for granted. We’ve simply grown up with cures and treatments for illnesses and disorders that just a few years ago, made so many lives painful or cut them tragically short.
Views: 736 CSL Plasma
All About Clinical Trials
 
04:59
This is a video my team made as a proof-of-concept for Takeda Pharmaceuticals as part of University of Illinois' STEM Learning Exchange R & D Program. The challenge was to create a way to promote clinical trail participation in minors, especially in minorities and smaller demographics. This is about the clinical trial process and was made to appeal to high school teens. Takeda did not sponsor this video but I would like to thank them for working with us and giving me and my team this valuable experience. If you have any questions about clinical trials please ask in the comments, I would be happy to answer any of your questions. If you are presented with the opportunity to do so, I would encourage you to participate in a clinical trial. Thanks to my teammates: Reuben, Christopher, and Aiden. Song: Feeling Good by Purple Planet Music Twitter: @dropthehammer13
Views: 56 dropthehammer13
【Touhou hand-drawn】Meth 101 with Touhou【Philopon】(English subs)
 
16:11
Reprinted/translated with the creator's permission. 創作者様の許可を得て転載・翻訳しております。 Creator: ALISON http://www.nicovideo.jp/user/16017786 http://www.pixiv.net/member.php?id=2331748 Original title: 東方で学ぶ覚せい剤講座【ヒロポン】 Original link: http://www.nicovideo.jp/watch/sm20646030 Upload date: April 19, 2013. 21:35. Creator comment: "一限目 - 覚せい剤ってなに? 二限目 - 覚せい剤の歴史 三限目 - 疲労がポンっと取れる魔法の薬 四限目 - ようむ大佐とムラサ少尉による実演飛行 五限目 - ヒロポン家の敵!覚せい剤取締法の制定" Music 00:00 - 00:22 "The Four Seasons" by Antonio Vivaldi, unidentified performance 00:28 - 01:13 "ウルトラ警備隊の歌" from ウルトラセブン (Ultra Seven) 01:17 - 01:57 "DECISIVE BATTLE" from 新世紀エヴァンゲリオン (Neon Genesis Evangelion) OST 02:01 - 02:20 "DECISIVE BATTLE" from 新世紀エヴァンゲリオン (Neon Genesis Evangelion) OST 02:21 - 02:36 (which song?) from ストライクウィッチーズ (Strike Witches) OST 02:38 - 03:30 "DECISIVE BATTLE" from 新世紀エヴァンゲリオン (Neon Genesis Evangelion) OST 03:34 - 03:51 (which version of Mario's invincibility theme?) 03:52 - 04:22 "ストライカーの飛翔" from ストライクウィッチーズ (Strike Witches) OST 04:29 - 05:22 "メーサーマーチ" from ゴジラvsモスラ (Godzilla vs. Mothra) OST 05:25 - 05:39 (which version of Mario's invincibility theme?) 05:40 - 06:26 "ストライカーの飛翔" from ストライクウィッチーズ (Strike Witches) OST 06:29 - 06:41 突撃ラッパ (Imperial Japanese Army's attack bugle) 06:41 - 07:59 "軍艦行進曲" (Gunkan kōshinkyoku), unidentified performance 08:04 - 10:05 "怪獣大戦争マーチ" (Monster Zero March) (which version?) 10:07 - 10:40 10:44 - 11:04 "陸軍分列行進曲" (Rikugun bunretsu koushinkyoku), Japanese Army March, composed by Charles Leroux 11:05 - 11:48 "ストライカーの飛翔" from ストライクウィッチーズ (Strike Witches) OST 11:52 - 13:49 13:51 - 16:09 "In My Spirit" from ヱヴァンゲリヲン新劇場版:破 (Evangelion: 2.0 You Can (Not) Advance) OST Notes 02:43 - 02:49 "What drug is that?" "It's multi-vitamins" 03:16 - 03:23 "Y-You're Musubi!" 03:23 - 03:30 "Ngggh, it hurts, it hurts! Please, hurry up and give me a shot......" 04:12 - 04:21 "Left hineri-komi!!" 13:57 - 14:03 "N-No, it's just vitamins......" "You're lying, Musubi!" 14:03 - 14:09 "*pant pant*" 14:16 - 14:23 "Philopon Eradication Movement" "Philopon Kills Even Parents" "Enemy of the Household!" 15:07 - 15:14 "'Pon-head'?" "You don't know? You're behind the times......it's popular all around Japan right now......" 15:40 - 15:47 "Hii hii, p-please......hurry up and give me a shot......" *grin* The manga is はだしのゲン (Barefoot Gen). Translation/Subs: TouhouSubs
Views: 8350 TouhouSubs
ESGO 2017 Congress Vienna
 
02:28
The 20th International Meeting of the European Society of Gynaecological Oncology is the landmark event you don't want to miss in 2017...from November 04-07 in Vienna, Austria   Join over 2,800 attendees from around the world for a 4 days gathering of learning, networking and sharing the latest developments in the field of Gynaecological Cancers.
Uso correcto de un monitor de presion arterial de brazo
 
01:02
Te enseñamos el funcionamiento correcto de un baumanómetro o monitor de presión arterial. OMRON para brazo. Toma correctamente tu presión y Cuida tu salud. visita www.valoratusalud.com.mx para más información.
Views: 88473 Omronsalud
FirstWord Pharma Daily News Round-Up Video for August 26, 2016
 
01:51
The FirstWord Pharma Daily News Round-Up Video gives a recap of the latest pharmaceutical and biotechnology news. Stay abreast of the key industry news each day. Today's video highlights include Takeda, Mylan, EpiPen, Teva and FDA.
Views: 75 FirstWordPharma
Orexigen Slumps As FDA Staff Questions New Diet Pill
 
00:37
"Orexigen Therapeutics (OREX) shares are down sharply in Friday pre-trade after U.S. Food and Drug Administration staff questioned whether the firm's new diet pill Contrave is effective. Contrave reportedly satisfied only one of two recommended measures of effectiveness in the FDA studies and the drug was linked to more cases of high blood pressure, psychiatric side effects, dizziness and kidney dysfunction."
Views: 146 FinancialNewsOnline
3-Axis CNC drilling machine with X Y Z parameters
 
04:26
Please contact us for more information: Ph: +91 9490219339 (WhatsApp/SMS text only Please) www.sooxma.com www.mycollegeproject.com engprojects@gmail.com Hyderabad, India. Students will be provided with complete working hardware kit and other related documentation. We develop customised projects as per your requirements. We are specialised in developing IoT based industrial projects usinng various sensor like Temperature, Humidity, light, water level, moisture, pressure, fire, flame sensor, air pollution, gas sensors like MQ-02,MQ-03,MQ-06 etc. Alcohol sensrs, LPG gas, LDR sensor, current CT sensor, voltage sensor for solar panels, IR (infrared) sensors, Laser light sensors, Magnetic sensors like hall effect, read switch etc, tilt sensor, sound sensor, heart rate sensor, blood pressure sensor, body temperature sensor, rain water sensor, ultrasonic distance sensor, Thermisters, PIR sensor, MEMS accelerometer sensor, Digital compass, positional sensor, Direction sensors, RTC, EEPROM, iButton reader, piezo sensors, wireless power, Load cell, weight sensors, flex sensors, Flow sensors, Resistive touch screen, APR voice module, Eye blink sensor, DHT11, LM35, Speech recognition, mp3 player, Barcode reader, color sensor, Capacitive touch sensor, energy meter, Matrix keypad, SD card reader, Tachometer (speed sensor), Nextion displays, Fuel sensors, Vibration sensor, LiFi. Motors we work with: DC Motor, PMDC motors, Servo Motor, AC Motor, Series motor, Universal motors, stepper motors, geared motors, brush less motors. We work with following communication devices. GSM Modem, GPS Receiver, IoT esp8266, RFID readers (Active and Passive), Zigbee, Bluetooth receivers, WiFi transceivers, RS232 communication, RS485, CAN communication, RF Transceiver, RF 433MHz, PLCC (Power line Carrier Communication), barcode reader, finger print reader, smart card reader, USB communication, PS2 communication, DTMF, Ethernet communication, We work with PIC Microcontrollers (8bit, 16bit, 32 bit), MSP430, PIC 12F, PIC16F, PIC18F, PIC24F, PIC32F series, STM32, Arduino (Pro mini, Nano, Uno etc), AVR, ATMEGA, esp8266, 8051, 80S52, ARM, LPC2148, Raspberry Pi, Orange Pi(Lite,One,Plus etc), Nodemcu, Wemo etc. WE develop following Hardware(sensors) accessing mechanisms: Android apps, PC based applications, Web development with IoT, TCP sockets, UDP, http, remote file systems and data loggers. Domains we work with: Security, SCADA, wireless, protection, data loggers, control systems, telecommunications, education, transport, agricultural, industrial, building autommation, home automation, access control, IoT with Android apps, solar, non-conventional power generation, medical, Robotics, advertisement displays (scrolling led sign board, P10 displays, 50-50 led sign board, pixel programmable led sign board, Displays we work with: Nokia 5110, Propeller display, 16x2 LCD displays, 20x4 displays, scrolling led displays, 128x64 graphical displays, oled (spi,i2c), TFT displays, seven segment displays, Power electronics and Switching devices: MOSFET, Transistor, Power Transistor, IGBT, SCR, TRIAC, Relays etc. We also develop IEEE projects like IEEE-2016, IEEE-2017 Student projects along with modifications.
Views: 2013 sooxma
Seattle Genetics Announced It Will Recieve A $5M Milestone Payment
 
00:47
Seattle Genetics (NASDAQ:SGEN) announced that it will receive a $5 million milestone payment under its collaboration with Takeda Pharmaceutical Company Limited's wholly owned subsidiary. The milestone was triggered by the European Medicines Agency acceptance of the Marketing Authorization Application for brentuximab vedotin for the treatment of relapsed or refractory Hodgkin lymphoma and relapsed or refractory systematic anaplastic large cell lymphoma. Seattle Genetics is currently above its 50-day moving average (MA) of $18.14 and above its 200-day of $15.98.
Targeted Medical Pharma's Dr. Fred McCall-Perez Discusses Results of Rx Sleep Survey
 
01:38
Targeted Medical Pharma's (OTCQB: TRGM) Dr. Fred McCall-Perez, Ph.D., discusses the results of the company's 2013 Rx Sleep Survey and American attitudes toward pharmaceutical drugs for getting a good night's rest. Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops prescription medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. Dr. McCall-Perez has more than 25 years of clinical, management and development experience in managed care, disease management and healthcare consulting to physician practices, integrated delivery networks, pharmaceutical and healthcare technology companies. He has worked in a number of high level healthcare and medical technology positions throughout his career, including founder and CEO of LifeWay Disease Management, president of American Biodyne (now Magellan) and president of the disease management division at National Health Enhancement Systems. Dr. McCall-Perez, who has published more than 25 professional articles and the book, "Physician Equity Groups and Other Emerging Entities," was the first medical adviser for WebMD and served as president of Healthonline.com. He also served as a White House representative on healthcare reform during the Clinton administration.
Aparelho de Pressão Digital de Braço Automático Desktop Geratherm - Fibra Cirúrgica.wmv
 
04:26
Para adquirir esse produto acesse nosso site: http://www.fibracirurgica.com.br/produtos/detalhe.php?ref=702974&linhas=12&p=APARELHO_DE_PRESSAO_DIG_DE_BRACO_AUTO_DESKTOP_GERATHERM Monitor de Pressão Arterial Digital Automático de Braço Desktop é indicado para uso profissional e domiciliar, com braçadeira lavável ele pode ser levado a qualquer lugar com sua caixa em acrílico para armazenamento. Memoriza 42 medições com data e hora e ele ainda é totalmente automático desinflando e inflando automaticamente e com insuflação com compressão programada faz dele um medidor muito confortável. Possui ainda grande visor de cristal liquido e entrada para adaptador elétrico.
Views: 35201 fibracirurgica
Taking Medicine Personally: Addressing Emerging Patient Needs
 
32:30
Successful medical solutions are personalized, says Novartis Pharmaceuticals Corporation President, Christi Shaw. In a keynote speech, she told DiversityInc's audience how the drug company is using its knowledge of diverse populations - and its emphasis on an inclusive and innovative workplace - to create the most effective medicines.
Views: 729 DiversityInc
Kaoru Ito
 
12:17
Views: 1555 Shinpei Takeda
How to reverse your kidney disease - The kidney disease solution
 
11:38
Learn how to reverse your kidney disease - The kidney disease solution: To find out more click here: http://tinyurl.com/kidneydiseasesollution "How To Lower Creatinine Levels, Improve Kidney Function, and Safeguard Your Kidneys From Further Damage - Introducing An All Natural Step-by-Step Program, Proven To Start Healing Your Kidneys Today!" Medical Researcher, 2nd Generation Naturopath and Kidney Disease Expert, Teaches You How To: Reverse Your Impaired Kidney Function Naturally With Great Results Which Are Noticeable As Quickly As Within Weeks Heal Your Kidney Disease And Live A Better Quality Of Life By Making Simple Changes That Have Dramatic Results Improve Your Quality Of Life Even If You Are On Dialysis – This Guaranteed Method Assists Kidney Function – Even If You Are In “End Stage Renal Failure” Find Out What Secrets His Research Uncovered – Including Ancient Remedies, Not Commonly Known, Till Now – that can help you: Recover Your Health Without Using Drugs Reverse Your Impaired Kidney Function Avoid Dialysis Avoid Kidney Surgery Reduce Your Specialist Visits So ... Getting This Information Is Very Important – Every Day Counts when you are managing kidney disease. Introducing: Duncan Capicchiano ND, fully Qualified Naturopath, Nutritionist, Herbalist, Medical Researcher and author! Find out more information here: http://tinyurl.com/kidneydiseasesollution https://youtu.be/Mdv0KiFmxiU
Views: 364 Patrik Thid
N. Anthony Coles, MD, Chairman & CEO, Onyx Pharmaceuticals, Inc.
 
00:43
N. Anthony Coles, MD Chairman & CEO, Onyx Pharmaceuticals Dr. Coles joined Onyx in March 2008 as President and Chief Executive Officer. In 2012, Dr. Coles was appointed as Chairman of the board of directors. Prior to joining Onyx, he was President, Chief Executive Officer, and a member of the board of directors of NPS Pharmaceuticals, Inc. Before joining NPS Pharmaceuticals in 2005, Dr. Coles was Senior Vice President of Commercial Operations at Vertex Pharmaceuticals Incorporated, which he joined in 2002. Beginning in 1996, he held a number of executive positions while at Bristol-Myers Squibb Company, including Senior Vice President of Strategy and Policy; Senior Vice President of Marketing and Medical Affairs, Neuroscience/Infectious Diseases/Dermatology; Vice President, Western Area Sales Cardiovascular and Metabolic Business Unit for U.S. Primary Care; and Vice President, Cardiovascular Global Marketing. From 1992 until 1996, Dr. Coles also held a number of positions of increasing responsibility at Merck & Co., Inc., including Vice President of the Hypertension and Heart Failure Business Group Dr. Coles completed his cardiology and internal medicine training at Massachusetts General Hospital and was a research fellow at Harvard Medical School. He earned an M.D. degree from Duke University, a master's degree in public health from Harvard University, and an undergraduate degree from Johns Hopkins University. Dr. Coles currently serves as a trustee and member of the Executive Committee for the Johns Hopkins University Board of Trustees, as well as a member of the board of trustees for Johns Hopkins Medicine. Dr. Coles is also a member of the board of directors for Laboratory Corporation of America (LabCorp), as well as Campus Crest Communities, Inc., both NYSE traded companies. He is also a member of the board of the Biotechnology Industry Organization (BIO).
What is headache?
 
00:58
Eric P. Flores, M.D., DABNS, DPBNS is currently a Neurology at Makati Medical Center. He answers frequently asked questions regarding migraine, headache, and brain tumor. For more information about Neurologist, and how to contact Dr. Eric P. Flores, please visit our website at www.pinoymed.com.
Views: 296 pinoymedhealthtips
Diabetic issues Medicine: Can Your Course of action Bring
 
00:54
http://visionwithoutglasses.allalla.com Inside of 1997, the health-related neighborhood was prescribing a refreshing drug towards address fashion 2 diabetic issues. Via March 2000, this drug was taken out against the sector for the reason that it was resulting in hepatitis and liver illness. Medicines within this spouse and children are however currently being approved towards take care of diabetic issues. Are there any pitfalls? Troglitazone was allegedly a wonder drug. It minimized event of design 2 diabetic issues through up in the direction of 75% in contrast with a manage neighborhood. It served decrease a great number of problems that can occur towards insulin resistance, which include confident ovarian disorders. It was recommended towards retain the services of with insulin, with other diabetic issues drugs, and by means of alone for procedure. Basically following 3 yrs did the Food and drug administration (Food items and Drug Management) recognize that troglitazone brought on really serious liver problems. Troglitazone was out there beneath the model names Rezulin and Romozin. Troglitazone is within just the thiazolidinedione household of diabetic issues medicine. The thiazolidinedione household features pioglitazone and rosiglitazone. Pioglitazone is sold as Actos as a result of Takeda Pharmaceuticals; Rosiglitazone is sold as Avandia via GlaxoSmithKline. Possibly of these kinds of drugs are previously upon the industry. Neither Avandia nor Actos contain been involved with an strengthen inside liver condition. Sadly, either of Those people prescription drugs may perhaps lead to an boost likelihood of middle assault and stroke. It is sizeable that your self go over any factors that on your own contain with your physician prior to accomplishing any procedure. Equally Avandia and Actos can be made use of as monotherapies (as a result of by themselves) toward support boost the overall body's sensitivity in the direction of insulin. They can much too be applied with insulin course of action, for design and style 2 diabetics who are insulin based mostly. Avandia and Actos can be utilised inside of mix with other diabetic issues medication, these types of as biguanides (this sort of as metformin) and sulfonylureas. Avandia is obtainable within just pre-blended combos referred to as Avandamet and Avandaryl. Inside buy in direction of ease your possibility of facet repercussions upon diabetic issues medicines versus the thiazolidinedione family members, this sort of as Actos and Avandia, it is crucial in the direction of comply with your health practitioner's guidance. This suggests that oneself will include towards adhere to your diet program and fitness schedule. It much too signifies that oneself will incorporate in direction of reduce your alcoholic beverages usage. By yourself will not be capable in direction of get a thiazolidinedione if by yourself consist of a heritage of liver ailment, or if oneself comprise a historical past of center sickness. Medical professionals normally keep track of individuals' livers While they are upon Avandia, Actos, or other thiazolidinedione given that of the last scare with Rezulin. Your liver feature can be monitored with month-to-month blood checks, typically just about every thirty day period or every single other thirty day period. Be confident toward pay a visit to your physical fitness treatment proficient continuously toward incorporate your watch ups. The very simple characteristic of diabetic issues control, no make a difference your method, is preserving a wholesome diet program and physical fitness. This can usually stay away from on your own in opposition to feeding on in the direction of consider medicine in direction of deal with your diabetic issues, or it can assistance on your own alleviate the total of medications that by yourself want. Avoidance is occasionally the excellent medications of all.
Views: 98 paula vela
Health Breaking News: Study: For Timely Access to Care, Patients May Seek a New Path
 
01:05
Study: For timely access to care, patients may seek a new path A new study by the Association of American Medical Colleges says that although about half of U.S. consumers prefer physicians for primary health care, patients are willing to be treated by physician assistants and nurse practitioners to secure timely access to care, http://rssfeeds.usatoday.com/~r/usatoday-NewsTopStories/~3/vx_FFGe7P0U/ Arizona Government Claims A Win As House Approves Medicaid Expansion Plan The Arizona House passed an $8.8 billion state budget that includes a proposal to pursue the health law's Medicaid expansion. http://feeds.kaiserhealthnews.org/~r/khn/~3/MwKfDnwhCGc/medicaid-expansion.aspx Pfizer Settles Patent Lawsuit for $2.15 Billion Pfizer said it reached a $2.15 billion settlement with Teva Pharmaceuticals Industries and Sun Pharmaceutical Industries related to patent infringement on its acid-reflux drug Protonix. Japan's Takeda Pharmaceutical Co Ltd, Pfizer's partner, will receive 36 percent or about $774 million from the settlement. Israel-based Teva will pay $800 million in 2013 and the remaining $800 million by October 2014. http://www.nytimes.com/reuters/2013/06/12/business/12reuters-pfizer-patent.html?partner=rss&emc=rss http://www.wochit.com
Views: 44 Wochit News
Papantonio: Diabetes Drugs Linked To Cancer - The Ring Of Fire
 
08:38
The following interview originally aired on the May 12th episode of Ring of Fire on Free Speech TV (http://www.freespeech.org/RingofFire). The diabetes drug Actos has been linked to seriously severe risks, including bladder cancer. Recently, a jury in California ruled against the maker of Actos. Ring of Fire host Mike Papantonio discusses that ruling with attorney Robert Price, and what it means for consumers. Watch Ring of Fire every Sunday at 12pm Eastern/9am Pacific on Free Speech TV! Follow more of our stories at http://www.RingofFireRadio.com Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557
Views: 726 The Ring of Fire
UNC-Chapel Hill, GSK Announce Partnership to Focus on HIV Cure
 
41:08
The University of North Carolina at Chapel Hill, a leading global public research university with significant expertise in HIV basic and clinical research, and GSK, a global, research-based pharmaceutical and healthcare company with a legacy of success in developing treatments for HIV, today announced the creation of the dedicated HIV Cure center and a jointly owned new company that will focus on discovering a cure for HIV/AIDS. This unique public-private partnership will redefine the traditional way of conducting research and create a new model to seek the breakthroughs needed to tackle an extraordinarily challenging global health issue. Read the full story here: http://www.unc.edu/spotlight/livestream-carolina-gsk-announce-novel-partnership-to-accelerate-search-for-hiv-cure/
Views: 335 UNC-Chapel Hill
NHK WORLD TV - 22 November 2016 - 06:00 JST - Fukushima Earthquake
 
08:00:09
NHK Newsline was interrupted at 06.08.30 JST by tsunami alert following the 2016 Fukushima Eartquake, which was slower than alert interrupting "Good Morning Japan" on NHK G at 06.00 JST.
Views: 2615 Ahmad Ikhyari
Understanding Insomnia Part 7   Not sleeping? Wondering   what is insomnia? Find out now
 
07:54
Not sleeping? Wondering, "what is insomnia?" Find out now... What is insomnia? Insomnia is when you have trouble sleeping night after night. As surprising as this may sound to some, many people essentially forget how to sleep or they have trouble sleeping so many nights in a row (or so many years in a row) that they start to psych themselves out and create a lot of sleep anxiety for themselves. No matter what initially causes their trouble sleeping, after a while, this sleep anxiety alone can create their insomnia. If you're someone who is not sleeping on a regular basis or has, in some ways, forgotten how to fall asleep, you are suffering from insomnia. What Causes Insomnia? There are 7 main insomnia causes - sleep anxiety, depression, stress, beliefs and attitudes about sleep, sleep hygiene, lifestyle habits and medical problems. For most people who are not sleeping, it will be a combination of a few of those 7 insomnia causes that, together, are causing their trouble sleeping. If you are having trouble sleeping or find yourself thinking "I cant sleep" or wondering "why cant i sleep?," then it's extremely important for you to which of these 7 causes of insomnia is keeping you awake at night. Answering the questions "why cant i sleep" is the first step towards the cure for insomnia. This video will look in-depth at one of the 7 main causes of insomnia - Medical problems. It will explain common medications and medical issues that affect sleep and provide you with a questionnaire that will help you determine whether medical issues might be contributing to your unique case of insomnia. Once you fully understand the causes of insomnia, the next step is to figure out how to go to sleep. This video contains a link to more free videos that will teach you the step-by step process for how to fall asleep easily and effortlessly. So if you're not sleeping- don't risk another sleepless night. Watch this video, answer the questions "what is insomnia" and then go to the other free videos to find out how to get to sleep. Get the cure for insomnia now! http://youtu.be/b1xy_bn_h-A
Views: 233 Jessica Eagan
Prof Korczyn EAN Berlin Symposium 2015 Post-stroke cognitive impairment-challenges and new treatment
 
20:21
In a session on Post-stroke dementia conducted during the First Congress of the European Academy of Neurology, Takeda presented their product Actovegin. The topic discussed by Professor Korczyn related to the appearance of mild cognitive impairment after a vascular event in the brain (ischemia, hemorrhage etc)
Views: 96 Amos Korczyn
Sue & Lonnie Carpenter
 
15:37
Views: 1035 Shinpei Takeda
Ayurveda Formulation for Paget's Disease of Bone - Pankaj Oudhia's Ethnobotanical Surveys-1914
 
00:17
Medicinal Plants of India with reference to Healing Flora of Andhra Pradesh, Assam, Karnataka, Kerala, Chhattisgarh, Gujarat, Jharkhand, Madhya Pradesh, Maharashtra, Meghalaya, Sikkim, Arunachal Pradesh, Orissa, Rajasthan, Tamilnadu, Punjab, Haryana, West Bengal, Uttarakhand and Uttar Pradesh. - This video is a part of Compilation of Pankaj Oudhia's Research Works at Indira Gandhi Agricultural University, Raipur, India (1990-2001), - For details please visit http://www.pankajoudhia.com Life Saving Medicinal Plants from Pankaj Oudhia's Medicinal Plant Database at Flickr http://www.flickr.com/photos/pankajoudhia/ http://scribd.com/pankajoudhia ( Also at Scribd--Pankaj Oudhia's series on Interesting Stories behind the Names of Plants in India. 1-100) Compatible Herbs Uvaria narum (Dunnal) Wall. ex Wight & Arn. Uvaria zeylanica L. Xylopia parvifolia (Wight) Hook. f. & Thoms. Anamirta cocculus (L.) Wight & Arn. Cissampelos pareira L. var. hirsuta (Buch.-Ham. ex DC.) Forman Cocculus hirsutus (L.) Diels Cocculus laurifolius DC. Cocculus pendulus (Forst.) Diels Coscinium fenestratum (Gaertn.) Coleb. Cyclea arnottii Miers Cyclea peltata (Lam.) Hook. f. & Thoms. Diploclisia glaucescens (Blume) Diels Pachygone ovata (Poir.) Miers ex Hook. f. & Thoms. Stephania japonica (Thunb.) Miers Stephania wightii (Arn.) Dunn Tiliacora acuminata (Lam.) Hook. f. & Thoms. Tinospora cordifolia (Willd.) Miers ex Hook. f. & Thoms. Tinospora sinensis (Lour.) Merr. Berberis lycium Royle Berberis nilghiriensis Ahrendt Berberis tinctoria Lesch. Berberis wightiana Schneid Mahonia leschenaultii (Wall. ex Wight & Arn.) Takeda Nelumbo nucifera Gaertn. Nymphaea nouchali Burm. f.
Views: 235 Pankaj Oudhia